GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Market Cap

4basebio (LSE:4BB) Market Cap : £180.55 Mil (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 4basebio's share price for the quarter that ended in Jun. 2023 was £5.75. 4basebio's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 12.32 Mil. Therefore, 4basebio's market cap for the quarter that ended in Jun. 2023 was £70.84 Mil.

4basebio's quarterly market cap increased from Jun. 2022 (£52.35 Mil) to Dec. 2022 (£87.45 Mil) but then declined from Dec. 2022 (£87.45 Mil) to Jun. 2023 (£70.84 Mil).

4basebio's annual market cap increased from Dec. 2020 (£0.00 Mil) to Dec. 2021 (£75.75 Mil) and increased from Dec. 2021 (£75.75 Mil) to Dec. 2022 (£87.45 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 4basebio's Enterprise Value for Today is £179.55 Mil.

4basebio Market Cap Historical Data

The historical data trend for 4basebio's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Market Cap Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Market Cap
- - 75.75 87.45

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Market Cap Get a 7-Day Free Trial 56.29 75.75 52.35 87.45 70.84

Competitive Comparison of 4basebio's Market Cap

For the Biotechnology subindustry, 4basebio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Market Cap distribution charts can be found below:

* The bar in red indicates where 4basebio's Market Cap falls into.


4basebio Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

4basebio's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=£7.1*12.3175
=£87.45

4basebio's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=£5.75*12.3195
=£70.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio  (LSE:4BB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

4basebio Market Cap Related Terms

Thank you for viewing the detailed overview of 4basebio's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Market Cap
Comparable Companies
LSE:ETX LSE:AREC LSE:OBD LSE:DEST LSE:SBTX LSE:SAR LSE:FUM LSE:TRX LSE:REDX LSE:C4XD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
88Q:Germany
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines